Table 1. Metastatic Melanoma Treatments and Effects.
Treatment | Partial response (decrease in tumor size by at least 50%) | Complete response (no tumor detectable) | Overall Response | Median Overall Survival | Reference |
---|---|---|---|---|---|
Biochemotherapy vs. Chemotherapy | 21% vs. 15% | 7% vs. 3.5% | 28% vs. 18.5% | No difference | 2 |
Interleukin 2 | 10% | 6% | 16% | 11.4 months | 7 |
Ipilimumab vs. Chemotherapy | 13.6% vs. 9.5% | 1.6% vs. 0.8% | 15.2% vs. 10.3% | 11.2 months vs. 9.1 months | 20 |
Vemurafenib vs. Chemotherapy | 47% vs. 5% | 1% vs. 0% | 48% vs. 5% | At 6 months: 84% vs. 64% | 22 |